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SCIENTIFIC OPINION 
Scientific Opinion related to a notification from the International 
Organisation of Vine and Wine (OIV) on casein/caseinate/milk products to 
be used in the manufacture of wine as clarification processing aids 
pursuant to Article 6, paragraph 11 of Directive 2000/13/EC – 
for permanent exemption from labelling
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) was asked to deliver a scientific opinion related to a notification from the International Organisation of 
Vine and Wine on casein/caseinate/milk products to be used in the manufacture of wine as clarification 
processing aids pursuant to Article 6, paragraph 11 of Directive 2000/13/EC – for permanent exemption from 
labelling. In earlier assessments, the Panel concluded that wines fined with casein/caseinate/milk products may 
trigger adverse reactions in susceptible individuals under the conditions of use stated by the applicants based on 
the limited information provided on the characterisation of the fining agents, on the limitations of the methods 
used to quantify casein and other milk allergens in wine, and on the clinical studies presented, which were 
inconclusive. This application refers to new analytical methods developed for the detection of milk allergens in 
the fining agent and the detection of casein in wine. There were no changes in the wine manufacturing process 
and no new clinical studies were provided. Taking into account the information provided on the characterisation 
of the fining agents regarding their content of milk proteins other than casein, the lack of standardisation of the 
wine manufacturing process, and that no new clinical data have been provided in the present application, the 
Panel concludes that wines fined with casein/caseinate/milk products may trigger adverse reactions in susceptible 
individuals under the proposed conditions of use. © European Food Safety Authority, 2011 
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Wine, fining agents, milk products, casein, food allergy. 
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SUMMARY 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and 
Allergies (NDA) was asked to deliver a scientific opinion related to a notification from the 
International Organisation of Vine and Wine on casein/caseinate/milk products to be used in the 
manufacture of wine as clarification processing aids pursuant to Article 6, paragraph 11 of Directive 
2000/13/EC – for permanent exemption from labelling. 
Taking into account that the prevalence of allergic reactions to milk proteins, and particularly to 
casein, among the general population of adults has been reported to be around 0.5-1.0 %, it is 
appropriate for the Panel to assess the likelihood of adverse reactions in allergic individuals 
consuming products where casein/caseinate/milk products have been used during the manufacturing 
process. 
Three applications submitted for permanent exemption from labelling were the basis for earlier EFSA 
assessments of casein/caseinate/milk products as fining agents in the production of wine. The Panel 
concluded that wines fined with casein/caseinate/milk products may trigger adverse reactions in 
susceptible individuals under the conditions of use stated by the applicants. The conclusion was based 
on the limited information provided on the characterisation of the fining agents, on the limitations of 
the methods used to quantify casein and other milk allergens in wine, and on the limited information 
provided in relation to the clinical studies presented, which were inconclusive.  
This application contains new information and data mainly with regard to analytical methods 
developed for the detection of milk allergens in the fining agent and the detection of casein in wine. 
There were no changes in the wine manufacturing process and no new clinical studies were provided.  
Commercial preparations of milk-based fining agents sold as “casein/caseinate” may contain 
proteinaceous materials in addition to casein. Milk allergens other than casein were found in every 
milk-based fining product examined. The Panel notes that milk-based fining agents have not been 
sufficiently characterised in the application regarding their content of milk proteins other than casein. 
Cow’s milk-based fining preparations are used in particular for the treatment of astringency and for 
the clarification of white and rosé wines, but are also sometimes used with red wines. The Panel notes 
that the recommended amounts of casein/potassium caseinate/milk products to be added to wine as 
fining agents, as well as the manufacturing process and steps recommended to decrease residual 
allergens in wine, are very variable, and that according to the applicant no changes in the 
manufacturing process have been introduced since the last application.  
Two reports on the detection of casein in wine were provided. The Panel notes that, in the new 
analytical studies provided by the applicant, casein was detected in trace amounts (<2 mg/L) in two 
(out of 32) experimental wines without bentonite treatment and in three (out of 61) commercial wines 
with unknown treatment, and that the results from an Italian study which showed no detectable 
amounts of casein in any of the 63 commercial wines tested cannot be extrapolated to a random 
sample of commercial wines due to the consistent use of non-mandatory manufacturing practices 
(microfiltration, bentonite treatment) which may have affected proteinaceous fining agent residues in 
the wine. The Panel also notes that these studies do not adequately address the presence in wine of 
other milk allergens contained in caseinates for which the ability (and limit of detection) of the 
analytical methods used have not been reported, and that no new analytical data on wines fined with 
milk products other than “casein/caseinate” have been provided. The Panel considers that although 
the sensitivity and performance of the methods used for the detection of casein in wine have improved 
relative to previous applications, the studies provided by the applicant do not provide information 
about the levels of residual casein or other milk allergens which may be found in commercial wines 
fined with casein/caseinate/milk products under the proposed conditions of use. 
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Taking into account the information provided on the characterisation of the fining agents regarding 
their content of milk proteins other than casein, the lack of standardisation of the wine manufacturing 
process, and that no new clinical data has been provided in the present application, the Panel 
considers that the improvement on the methods used for the detection of casein in wine and the new 
analytical studies provided are insufficient to change its previous conclusion about the likelihood of 
adverse reactions triggered in susceptible individuals by the consumption of wines fined with 
casein/caseinate/milk products. 
The Panel concludes that wines fined with casein/caseinate/milk products may trigger adverse 
reactions in susceptible individuals under the conditions of use proposed by the applicant. 
 
Casein/caseinate/milk products in wine 
 
 
4 EFSA Journal 2011;9(10):2384 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 4 
Background as provided by the European Commission .......................................................................... 5 
Terms of reference as provided by the European Commission ............................................................... 5 
Assessment ............................................................................................................................................... 6 
1. Characterisation of the fining agent ................................................................................................ 6 
2. Conditions of use ............................................................................................................................. 7 
3. Analysis of residual allergens in wine ............................................................................................. 8 
4. Estimated level of exposure............................................................................................................. 9 
5. Evidence of non-allergenicity ........................................................................................................ 10 
5.1. History of non-allergenicity of the product .......................................................................... 10 
5.2. Animal studies ...................................................................................................................... 10 
5.3. Clinical studies...................................................................................................................... 10 
Conclusions ............................................................................................................................................ 10 
Documentation provided to EFSA ......................................................................................................... 11 
References .............................................................................................................................................. 11 
Glossary / Abbreviations ........................................................................................................................ 13 
Casein/caseinate/milk products in wine 
 
 
5 EFSA Journal 2011;9(10):2384 
BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Article 6, paragraph 11 of Directive 2000/13/EC
4 
establishes the cases and conditions for amending 
Annex IIIa to that Directive, which includes a list of food ingredients or substances known as likely to 
trigger allergic reactions in sensitive individuals. It also sets up a procedure for exempting from 
labelling, under certain conditions, derivatives of these ingredients. 
Pursuant to the procedure referred to above, a list of ingredients or substances derived from 
ingredients listed in Annex IIIa has been adopted by the Commission and is included in the Annex to 
Commission Directive 2007/68/EC
5
 of 27 November 2007, amending Annex IIIa to Directive 
2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. 
Applicants who are seeking the exclusion of a given product from Annex IIIa have to submit a 
request, completed with the results of relevant scientific studies. 
Therefore, in the context of the permanent labelling exemption procedure, the European Food Safety 
Authority is asked to provide scientific opinions on submissions in accordance with the present terms 
of reference. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29(1)(a) of Regulation (EC) N° 178/2002, the European Commission 
requests the European Food Safety Authority to evaluate the scientific data submitted by the 
International Organisation of Vine and Wine (OIV) in the framework of the procedure laid down in 
Article 6, paragraph 11 of Directive 2000/13/EC. On the basis of that evaluation, EFSA is requested 
to issue an opinion on the information provided, and in particular to consider the likelihood of adverse 
reactions triggered in susceptible individuals by the consumption of the following 
ingredients/substances used under the conditions specified by the applicant: casein/caseinate/milk 
products to be used in the manufacture of wine as clarification processing aids. 
                                                     
4  Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws 
of the Member States relating to the labelling, presentation and advertising of foodstuffs. OJ L 109, 6.5.2000, p. 29–42. 
5  Commission Directive 2007/68/EC of 27 November 2007 amending Annex IIIa to Directive 2000/13/EC of the European 
Parliament and of the Council as regards certain food ingredients. OJ L 310, 28.11.2007, p. 11–14.  
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ASSESSMENT 
Taking into account that the prevalence of allergic reactions to milk proteins and particularly to casein 
among the general population of adults has been reported to be around 0.5-1.0 % (EFSA, 2004), it is 
appropriate for the Panel to assess the likelihood of adverse reactions in allergic individuals 
consuming products where casein/caseinate/milk products have been used during the manufacturing 
process.  
Applications submitted by the Winemakers’ Federation of Australia (WFA) and the Australian Wine 
Research Institute (AWRI), and by the Deutscher Weinbauverband (DWV) and the Office National 
Interprofessionel des Fruits, des Légumes, des Vins et de l’Horticulture (VINIFLHOR), to the 
European Commission pursuant to Article 6, Paragraph 11 of Directive 2000/13/EC as amended by 
Directive 2003/89/EC
6
 for permanent exemption from labelling were the basis for earlier assessments 
of casein/caseinate/milk products as fining agents in the production of wine by the Panel on Dietetic 
Products, Nutrition and Allergies (NDA) (EFSA, 2007a, 2007b, 2007c). The Panel concluded that 
wines fined with casein/caseinate/milk products may trigger adverse reactions in susceptible 
individuals under the conditions of use stated by the applicants. The conclusion was based on the 
limited information provided on the characterisation of the fining agents, on the limitations of the 
methods used to quantify casein and other milk allergens in wine, and on the limited information 
provided in relation to the clinical studies presented, which were inconclusive.  
The present opinion is based on a dossier from the International Organisation of Vine and Wine 
(OIV), with an application for permanent exemption. This application contains new information and 
data mainly with regard to analytical methods developed for the detection of milk allergens in the 
fining agent and the detection of casein in wine. There were no changes in the wine manufacturing 
process and no new clinical studies were provided.  
1. Characterisation of the fining agent 
In previous submissions (EFSA, 2007a, 2007b, 2007c), milk-based fining agents sold as 
“casein/caseinate” and used as fining agents were characterised by the applicant using SDS-PAGE 
electrophoresis and, in parallel with Coomassie blue staining, with western blotting using the sera of 
milk allergic patients and of non-allergic controls. Different protein bands were detected. Sera from 
allergic patients were incompletely characterised. Tests were also performed using sera of rabbits or 
mice immunized with casein. Purified rabbit IgG recognized a total of 16 bands, most but not all 
corresponding to Coomassie blue staining. Human IgE recognized six bands at 22, 54, 67, 74, 130 and 
155 kDa. This implied that bands of high molecular weight unrelated to pure caseins (20-30 kDa) may 
have been related to aggregates or other immunoreactive proteins in the fining material. Thus, 
“casein/caseinate” which were used as fining agents in wine were a mixture of several proteins and 
may have contained residual amounts of other proteins (e.g. whey proteins), including allergens as 
impurities. 
In the present application, product sheets of milk-based fining agents sold as “casein/caseinate” as 
well as SDS-PAGE and immunoblotting studies have been submitted. Product sheets generally 
provide no information with regard to protein purity. Commercial preparations of the fining agents 
sold as “casein/caseinate” may contain added organic (e.g. gelatine, and egg white proteins) and 
non-organic (e.g. E558 bentonite or similar clay, E1202 polyvinylpyrrolidone (PVPP)) materials other 
than pure casein. The applicant claims that the commercial preparations of the fining agent used in the 
manufacturing of wine comply with the OIV and International Oenology Codex standards. 
                                                     
6  Directive 2003/89/EC of the European Parliament and of the Council of 10 November 2003 amending Directive 
2000/13/EC as regards indication of the ingredients present in foodstuffs. OJ L 308, 25.11.2003, p. 15–18. 
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Twelve different milk-based fining preparations were investigated by SDS-PAGE and 
immunoblotting as described by Weber et al. (2009). Milk allergens other than casein were found in 
every fining product. The applicant reported that in one milk-derived fining agent no casein was 
detected, but rather β-lactoglobulin. Weber et al. (2009) pointed out the importance of using 
antibodies capable of detecting all milk allergens (such as α-lactalbumin, β-lactoglobulin and bovine 
serum albumin), as well as their fragments, in the assessment of residual milk allergens in fined wine. 
The Panel agrees with this statement and notes that the application does not provide quantification of 
milk proteins other than casein finally present in the commercial fining preparations sold as 
“casein/caseinate”, and therefore possibly also in the wine.  
The Panel notes that milk-based fining agents have not been sufficiently characterised in the 
application regarding their content of milk proteins other than casein.  
2. Conditions of use 
Cow’s milk-based fining preparations are used in particular for the treatment of astringency and for 
the clarification of white and rosé wines, but are also sometimes used with red wines.  
In previous submissions (EFSA, 2007a, 2007b, 2007c), applicants described the winemaking process 
for different wines (red, white and rosé wines) that were produced in different regions. The 
winemaking process could vary according to the region, vintage and colour of the wine, as well as the 
skill of the winemaker. Fining is decided upon after evaluation of each particular batch of wine, as 
stated also in the present application. However, wine manufacturing was claimed to follow the 
professional guidance documents, namely Référentiel des pratiques oenologiques intégrées (ITV, 
2001) and Guide des bonnes pratiques hygiéniques filière vins (ONIVINS, 2000). The applicant states 
that the conditions of processing were similar in France and in Germany. The amount of casein added 
to wine usually ranges from 100 to 1000 mg/L, the amount of potassium caseinate from 200 to 1200 
mg/L, and the amount of skimmed milk powder from 20 to 200 mg/L (EFSA, 2007c). 
In the present application, the criteria and guidance documents set by the OIV regarding materials and 
procedures to be used in wine production were provided. The applicant states that the amount of 
casein added to wine usually ranges from 100 to 500 mg/L for white wines and from 50 to 250 mg/L 
for red wines. Potassium caseinate (100 to 500 mg/L), skimmed milk (approximately 15-30 mL/L, 
corresponding to 450-900 mg/L casein and 225-450 mg/L albumins), or powdered skimmed milk 
(approximately 530 mg/L, corresponding to about 140 mg/L casein) may alternatively be used. A 
typical dose to reduce bitterness and browning may be higher, between 500 and 1000 mg/L casein or 
potassium caseinate. Specifications for casein were set in 2003 (OIV, 2003). Reference is made to the 
guidance document regarding casein issued by the applicant in 2009 (OIV, 2009), and to a book from 
2000 (Ribéreau-Gayon et al., 2000).  
The principle of wine fining is to mechanically remove insoluble and colloidal substances from wine. 
This aims to clarify and stabilize the wine, and to preserve and improve its flavour and taste. Casein 
adsorbs phenolic compounds, particularly tannins, which may affect wine colour and taste. Casein 
coagulates and precipitates in the acidic environment of must and wine, and is usually removed by 
sedimentation, filtration and/or centrifugation. In previous submissions (EFSA, 2007a, 2007b, 2007c), 
the applicants stated that filtration may not be applied to certain wines, including some European 
wines. According to the literature provided, in some cases fining may be performed after filtration. A 
wide variety of the filtration materials and methods that may be used are described in the application. 
The applicant declared that no changes have been introduced in the manufacturing process with 
respect to previous applications. 
The Panel notes that the recommended amounts of casein/potassium caseinate/milk products to be 
added to wine as fining agents, as well as the manufacturing process and steps recommended to 
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decrease residual allergens in wine, are very variable, and that according to the applicant no changes 
in the manufacturing process have been introduced since the last application.  
3. Analysis of residual allergens in wine 
In a previous submission (EFSA, 2007c), no residual casein was detected with a competitive ELISA 
in five German wines fined with casein at concentrations of 60-300 or 100-500 mg/L depending on 
the wine. A wine experimentally fined with casein (500 or 1000 mg/L) in France was found positive 
(above 4 g/L) with a sandwich ELISA. Four hundred commercial French wines were also analysed 
for the presence of casein using this test. Thirteen were found positive for casein, including three 
organic wines, most of which were red wines (10 out of 13) (Lifrani et al., 2009).  
Two reports were provided in the present application, one from Germany (Paschke et al., 2010, 
unpublished) and one from Italy (Restani, 2010, unpublished). 
In the German report, one white wine was treated with different fining aids including casein (Paschke 
et al., 2010, unpublished). Casein was used at the maximum recommended dose (400 mg/L, OIV, 
2009) and at double the maximum recommended dose (800 mg/L) as a worst case scenario. The wine 
thereafter passed through pasteurization and filtering processes. Three different pasteurization and 
filtering processes were assessed: flash-pasteurization (72°C for 2 seconds), fine and sterile filtration 
using pad filters (“Seitz” K-100 and EK, respectively), and filtration with diatomaceous earth 
(Kieselgur). Casein residues in the wine were investigated with a newly developed indirect ELISA 
(Weber et al., 2009). The limit of detection (LOD) claimed in the application for this ELISA was 0.07 
mg/L; the limit of quantification (LOQ) was 0.09 mg/L. No residues of casein were detected in the 
wine, neither in the wine treated with the lower concentration of the fining agent nor in the wine 
treated with the higher. In the wine untreated post-fining (400 mg/L) and the wine treated with flash 
pasteurisation, 0.07 mg/L and 10.43 mg/L of casein were found, respectively. The investigators 
concluded that when the wine was filtered after fining under the conditions of use described in this 
study, residual levels of casein in wine were <0.07 mg/L both with the lower and the higher dose of 
fining agent. The Panel notes that only one experimental wine was tested. 
Further, in the German report, 16 Australian commercially available white wines not allergen labelled 
(n=5) or labelled with “may contain milk” (n=11, of which three were also labelled for egg) (Paschke 
et al., 2010, unpublished) were tested for casein residues with the same ELISA as above (Weber et al., 
2009). No casein residues were detected in any of these wines. The Panel notes that no information 
was provided on how these wines were selected for analysis. The Panel also notes that no information 
was provided about the manufacturing process (including doses of fining agent used) of these wines. 
The Panel therefore considers that this study provides information of only very limited value for use 
in the context of the present application.  
Finally, Weber et al. (2009) reported results from the testing of 32 experimental and 61 commercial 
white wines with the new ELISA. Two of 32 experimental wines fined with 300 mg/L caseinate and 
not treated with bentonite were found to contain detectable traces of casein (>0.2 mg/L but <2 mg/L), 
whereas no casein was detected when the wines had been additionally treated with bentonite or had 
been fined with a lower dose (i.e. 60 mg/L) of casein, with or without bentonite treatment. Further, 
among 61 commercial wines, three wines (one French, one German and one Italian) revealed casein 
traces (estimated up to 0.4 mg/L). The authors concluded that allergic reactions due to the 
consumption of casein-treated wines cannot be excluded. The Panel notes that the lowest dose of 
casein capable of triggering an allergic reaction in a sensitive individual is highly uncertain, but that 
reactions have been described to a dose of 300 mg of low-fat milk powder, which corresponds to 
approximately 105 mg of milk protein or 90 mg of casein (Lam et al., 2008), and that some case 
reports suggest significantly lower doses as capable of triggering reactions in highly sensitive 
individuals.  
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The report of an Italian study (Restani, 2010, unpublished) was also provided. Two experimental 
white wines and 63 commercial wines fined with “casein”, with or without bentonite treatment, 
(creating 16 different samples) were studied. Of these, 59 were white wines, two were rosé and two 
were red wines. Experimental wines were fined with “casein/caseinate” at doses of 200 and 
500 mg/L, whereas commercial wines were treated with “casein/caseinate” at doses from 20 mg/L to 
300 mg/L except for three samples (two used 350 and one 400 mg/L). All samples were microfiltered, 
and five of the six wines not treated with bentonite used tangential plus three-step microfiltration. The 
Panel notes that microfiltration and bentonite treatment are not mandatory steps in wine processing as 
recommended by the applicant (OIV, 2009), and that these may significantly affect the amount of 
residual fining agents in wine (Weber et al., 2009). Commercial wines were fined with 13 different 
commercial fining agents, most of which contained potassium caseinate (ranging from 65 to 100 % of 
the product by weight), two also contained bentonite, and one also contained montmorillonites and α-
cellulose.  
The most important physico-chemical characteristics of the wine samples were determined in order to 
assess their role in hindering or promoting the elimination of allergenic residues. Three different 
methods were used to detect caseinates in wine samples: ELISA test, SDS-PAGE with silver staining 
(Gromova and Celis, 2006) and immunoblotting with specific anti-caseinate antibodies. The ELISA 
test was specifically developed for the wine fining project, and was validated in a ring test of 12 
samples (three wines, spiked or not spiked) between 11 laboratories (Università degli Studi di Milano 
et al., 2011, unpublished). LODs for ELISA, SDS-PAGE with silver staining, and immunoblotting 
were found to be 0.28, 0.43 and 0.98 mg/L, respectively and LOQs were 0.76, 0.43 and 0.98 mg/L, 
respectively. All wine samples were found to be free of detectable allergenic residues. The Panel 
notes that although the sensitivity and performance of the methods used for the detection of casein in 
wine have improved relative to previous applications, the ability of the antibodies used to detect milk 
allergens other than casein fractions was not reported.  
In summary, the Panel notes that in the new analytical studies provided by the applicant, casein was 
detected in trace amounts (<2 mg/L) in two (out of 32) experimental wines without bentonite 
treatment and in three (out of 61) commercial wines with unknown treatment (Weber et al., 2009), 
and that the results from an Italian study which showed no detectable amounts of casein in any of the 
63 commercial wines tested cannot be extrapolated to a random sample of commercial wines due to 
the consistent use of non-mandatory manufacturing practices (microfiltration, bentonite treatment) 
which may have affected proteinaceous fining agent residues in the wine. The Panel also notes that 
these studies do not adequately address the presence in wine of other milk allergens contained in 
caseinates, for which the ability (and limit of detection) of the analytical methods used have not been 
reported, and that no new analytical data on wines fined with milk products other than 
“casein/caseinate” have been provided. 
The Panel considers that although the sensitivity and performance of the methods used for the 
detection of casein fractions in wine have improved relative to previous applications, the studies 
provided by the applicant do not provide information about the levels of residual casein or other milk 
allergens which may be found in commercial wines fined with casein/caseinate/milk products under 
the proposed conditions of use. 
4. Estimated level of exposure 
The applicant indicates that 26 % of French wines are fined with casein and 15 % with casein mixed 
with bentonite or PVPP. In Germany, 20 % of wines are fined with casein. Another source cited 
indicates that, globally, 30 % of wines are treated with casein. 
In a previous application, the applicant estimated the wine consumption in France to be around 60 L 
per person per year. In Germany the average consumption of wine was about 23 L per person in 2005. 
These and other published data on higher wine intakes (Weber et al., 2009) do not reflect variability 
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between individuals and geographical areas, nor variations for a given individual over time. The Panel 
notes that intake on a single occasion is more relevant regarding food allergic reactions than average 
daily or yearly intake. Further, the Panel notes that no generally applicable threshold levels of intake 
have been defined for food allergens (EFSA, 2004). 
No estimate of exposure to casein residues or other milk allergens through the consumption of fined 
wines was provided by the applicant. 
5. Evidence of non-allergenicity 
5.1. History of non-allergenicity of the product 
The applicant provided a general review on food allergens and particularly on milk allergens. 
Regarding milk products used as processing aids in this application and regarding the specific finished 
products that are concerned, reference to historical reviews was provided. The applicant stated that in 
the medical literature there is no indication of an allergenic potential of wine that has been fined with 
milk products, but no justification for this statement was given. The strategy and the sources used for 
the literature search were not described. The Panel notes that reactions to wine, including allergic 
reactions, are well documented (Armentia, 2008; Vally and Thompson, 2003). Since consumers and 
health professionals may be unaware that milk and milk-derived products are used in the winemaking 
process, allergic reactions to casein and other milk proteins have generally not been considered 
following allergic reactions to wine and therefore under-reporting of reactions caused by milk after 
ingestion of wines may have occurred.  
5.2. Animal studies 
Animal studies which were provided in previous applications were considered inconclusive by the 
Panel (EFSA, 2007c). No new animal studies were provided.  
5.3. Clinical studies 
Clinical studies which were provided in previous applications were considered inconclusive by the 
Panel with respect to the likelihood of adverse reactions triggered in susceptible individuals by the 
consumption of wines fined with casein/caseinate/milk products (EFSA, 2007c). No new clinical 
studies were provided with the present application.  
CONCLUSIONS 
Taking into account the information provided on the characterisation of the fining agents regarding 
their content of milk proteins other than casein, the lack of standardisation of the wine manufacturing 
process, and that no new clinical data have been provided in the present application, the Panel 
considers that the improvement on the methods used for the detection of casein in wine and the new 
analytical studies provided are insufficient to change its previous conclusion about the likelihood of 
adverse reactions triggered in susceptible individuals by the consumption of wines fined with 
casein/caseinate/milk products. 
The Panel concludes that wines fined with casein/caseinate/milk products may trigger adverse 
reactions in susceptible individuals under the conditions of use proposed by the applicant. 
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DOCUMENTATION PROVIDED TO EFSA 
Dossier submitted by the International Organisation of Vine and Wine (OIV) to the European 
Commission pursuant to Article 6, paragraph 11 of Directive 2000/13/EC as amended by Directive 
2003/89/EC, in July 2010. 
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GLOSSARY / ABBREVIATIONS 
AWRI  Australian Wine Research Institute 
DWV  Deutscher Weinbauverband 
ELISA  Enzyme-Linked Immunosorbent Assay 
LOD  Limit of detection  
LOQ  Limit of quantification 
OIV  International Organisation of Vine and Wine 
PVPP  Polyvinylpyrrolidone 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
VINIFLHOR Office National Interprofessionel des Fruits, des Légumes, des Vins et de 
l’Horticulture 
WFA  Winemakers’ Federation of Australia  
 
